Pathogenesis of prion diseases: current status and future outlook
The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Abstract
The prion, a conformational variant of a host protein, is the infectious particle responsible for transmissible spongiform encephalopathy (TSE), a fatal neurodegenerative disease of humans and animals. The principal target of prion pathology is the brain, yet most TSEs also display prion replication at extra-cerebral locations, including secondary lymphoid organs and sites of chronic inflammation. Despite significant progress in our understanding of this infectious agent, many fundamental questions relating to the nature of the prion, including the mechanism of replication and the molecular events underlying brain damage, remain unanswered. Here we focus on the unresolved issues pertaining to prion pathogenesis, particularly on the role played by the immune system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“prion diseases are caused in part (or at least accompanied by) the conversion of the prion protein PrP from its normal form PrPC to a conformationally distinct version PrPSc and that the latter can autocatalyse this conversion”
From Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples (2010) · cites this paper as Aguzzi and Heikenwälder 2006
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 1×
“For example, unmethylated cytosine phosphate guanosine (CpG) motifs present in bacterial DNA can stimulate mouse and human immune responses through TLR9 (Ref”
BackgroundThe Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782 · cited 1×
“Many chronic inflammatory conditions, some of which are very common and include rheumatoid arthritis, type-I diabetes, Crohn's disease, Hashimoto's disease and chronic obstructive pulmonary disease, result in organized inflammatory foci of B lymphocytes, FDCs, DCs, macrophages and other immune cells associated with ge…”
BackgroundThe TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
A new variant of Creutzfeldt-Jakob disease in the UK
Will, R. G., Ironside, J. W., Zeidler, M., Estibeiro, K., Cousens, S. N., Smith, P. G., Alperovitch, A., Poser, S., Pocchiari, M., & Hofman, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91412-9 · Cited by 2,707 · cited 1×
“Over the same period, transmission of BSE to humans is believed to have caused over 150 cases of a new variant of CJD (vCJD”
BackgroundMice devoid of PrP are resistant to scrapie
Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Aguet, M., & Weissmann, C. (1993) · Cell · doi:10.1016/0092-8674(93)90360-3 · Cited by 2,100 · cited 1×
“However, brain infectivity is only detected after 4–5 months post-inoculatio”
BackgroundSelf-citationTargeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
Collinge, J., Sidle, K. C. L., Meads, J., Ironside, J., & Hill, A. F. (1996) · Nature · doi:10.1038/383685a0 · Cited by 1,735 · cited 1×
“Over the same period, transmission of BSE to humans is believed to have caused over 150 cases of a new variant of CJD (vCJD”
BackgroundNormal development and behaviour of mice lacking the neuronal cell-surface PrP protein
Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S. J., Prusiner, S. B., Aguet, M., & Weissmann, C. (1992) · Nature · doi:10.1038/356577a0 · Cited by 1,655 · cited 1×
“33 ) and Prnp knockout mice were first constructed in 1992 (Ref”
BackgroundSensitive detection of pathological prion protein by cyclic amplification of protein misfolding
Saborio, G. P., Permanne, B., & Soto, C. (2001) · Nature · doi:10.1038/35081095 · Cited by 1,310 · cited 1×
“Protein misfolding cyclic amplification (PMCA) is also a promising method for the sensitive detection of the pathological prion protei”
MethodNMR structure of the mouse prion protein domain PrP(121–231)
Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R., & Wüthrich, K. (1996) · Nature · doi:10.1038/382180a0 · Cited by 1,257 · cited 1×
“The carboxyl terminus of PrP C is stabilized by a disulfide bond that links helices two and thre”
Background
Cited by
Items 101–200 of 215
A comparative molecular dynamics study on thermostability of human and chicken prion proteins
Ji, H., & Zhang, H. Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.194 · Cited by 16
Kouadir, M., Yang, L., Tu, J., Yin, X., Zhou, X., & Zhao, D. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1234 · Cited by 15
“…cleavage of the amyloid precursor protein (Yankner and Lu, 2009), whereas in prion diseases, the amyloid deposits are constituted mainly of the scrapie isoform of the prion protein (PrP Sc ), a conformational variant of the cellular prion protein (PrP C ) (Aguzzi and Heikenwalder, 2006).”
Singh, A. K., Mohan, M. L., Isaac, A. O., Luo, X., Petrák, J., Vyoral, D., & Singh, N. (2009) · PLoS ONE · doi:10.1371/annotation/194f4e44-20f0-48eb-bbe9-14e21d18909b · Cited by 15
Gug, F., Oumata, N., Tribouillard‐Tanvier, D., Voisset, C., Desban, N., Bach, S., Blondel, M., & Galons, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900314n · Cited by 14
Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice
Nakagaki, T., Ishibashi, D., Mori, T., Miyazaki, Y., Takatsuki, H., Tange, H., Taguchi, Y., Satoh, K., Atarashi, R., & Nishida, N. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00870-1 · Cited by 13
Rothwell, S. W., Settle, T., Wallace, S. M., Dorsey, J., Simpson, D. J. W., Bowman, J. R., Janmey, P. A., & Sawyer, E. S. (2010) · Biologicals · doi:10.1016/j.biologicals.2010.07.001 · Cited by 14
“Even prions, the putative causative agents for scrapie, Creutzfeldt-Jacob disease and other transmissible spongiform encephalopathies [18] do not seem to cross over between mammals and fish [19].”
BackgroundNovel aspects of tRNA-derived small RNAs with potential impact in infectious diseases
García-Silva, M. R., Cabrera-Cabrera, F., Güida, M. C., & Cayota, A. (2013) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2013.45a002 · Cited by 17
“The identification of non-invasive, sensitive and specific diagnostic markers during the pre-clinical phase is of major importance [42].”
Gourdain, P., Grégoire, S., Iken, S., Bachy, V. S., Dorban, G., Chaigneau, T., Dêbiec, H., Bergot, A., Renault, I., Aucouturier, P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804385 · Cited by 15
Dexter, E., & Kong, Q. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1965881 · Cited by 14
“However, this strategy carries multiple risks, since PrPC plays a negative role in several neurodegenerative diseases (such as PrD and AD) as well as in several types of cancer and other diseases.”
BackgroundInfluentialMatsui, Y., Satoh, K., Mutsukura, K., Watanabe, T., Nishida, N., Matsuda, H., Sugino, M., Shirabe, S., Eguchi, K., & Kataoka, Y. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9529-5 · Cited by 14
“erative disorders affecting humans and animals (Aguzzi and Heikenwalder 2006); the number of such disorders is Electronic supplementary material The online version of this article (doi:10.”
BackgroundWhy are prion diseases precluded by non-mammals?
Ji, H., Zhang, H., & Chen, L. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.03.004 · Cited by 14
Aetiology and pathophysiology of neurodegenerative disorders
Sahoo, R. K., Gupta, T., Smily, Kumar, V., Rani, S., & Gupta, U. D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00006-x · Cited by 19
Kang, S., Roh, Y.-M., Lau, A., Westaway, D. A., McKenzie, D. I., Aiken, J. M., Kim, Y., & Yoo, H. S. (2011) · Prion · doi:10.4161/pri.5.2.15621 · Cited by 13
Mutation directional selection sheds light on prion pathogenesis
Shen, L., & Ji, H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.007 · Cited by 13
Chang, J., Yang, L., Kouadir, M., Peng, Y., Zhang, S., Shi, F., Zhou, X., Yin, X., & Zhao, D. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9821-6 · Cited by 13
Glycosylation-related gene expression profiling in the brain and spleen of scrapie-affected mouse
Guillerme-Bosselut, F., Forestier, L., Jayat‐Vignoles, C., Vilotte, J.-L., Popa, I., Portoukalian, J., Ledur, A., Laude, H., Julien, R., & Gallet, P. (2009) · Glycobiology · doi:10.1093/glycob/cwp062 · Cited by 13
“…infection, we report the comparative expression profile of numerous glycosylation-related genes in the brain and spleen of healthy and prion-affected mice, as these two tissues contribute to prion replication (Aguzzi and Heikenwalder 2006) while having different glycomes (Comelli et al. 2006).”
BackgroundMethodCell Lines: Applications and Biosafety
Stacey, G., & Hawkins, J. R. (2016) · ASM Press eBooks · doi:10.1128/9781555819637.ch14 · Cited by 13
Optimal atomic-resolution structures of prion AGAAAAGA amyloid fibrils
Zhang, J., Sun, J., & Wu, C. (2011) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2011.02.012 · Cited by 12
A quantitative characterization of interaction between prion protein with nucleic acids
Bera, A., & Biring, S. (2018) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2018.04.006 · Cited by 14
Pradhan, P. C., Srivastava, A., Singh, J., Biswas, B., Saini, A., Siddique, I. A., Kumari, P., Khan, M. A., Mishra, A., Yadav, P. K., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.194479 · Cited by 12
Prion Protein Disease and Neuropathology of Prion Disease
du Plessis, D. (2008) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2007.12.003 · Cited by 16
Basu, U., Guan, L. L., & Moore, S. S. (2012) · Current Genomics · doi:10.2174/138920212801619223 · Cited by 14
“Human prion diseases include Kuru, Creutzfeldt-Jakob disease (CJD) for about 85% of the cases, familial CJD in 10-15% of the cases and variant CJD which is limited to the UK and France [1, 2].”
BackgroundInfluentialAlbus, A., Gold, M., Bach, J., Burg‐Roderfeld, M., Jördens, M., Kirchhein, Y., Kronimus, Y., Mengel, D., Zerr, I., & Dodel, R. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202954 · Cited by 11
PP2 and piceatannol inhibit PrP106–126-induced iNOS activation mediated by CD36 in BV2 microglia
Zhang, S., Yang, L., Kouadir, M., Tan, R., Lu, Y., Chang, J., Xu, B., Yin, X., Zhou, X., & Zhao, D. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt074 · Cited by 13
Self-replicating protein conformations and information transfer: The adaptive β-sheet model
Maury, C. P. J. (2008) · Bioscience hypotheses · doi:10.1016/j.bihy.2008.02.010 · Cited by 12
Shi, F., Yang, L., Wang, J., Kouadir, M., Yang, Y., Fu, Y., Zhou, X., Yin, X., & Zhao, D. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt101 · Cited by 10
Neurochemistry of myenteric plexus neurons of bank vole (Myodes glareolus) ileum
Sadeghinezhad, J., Sorteni, C., Guardo, G. D., D’Agostino, C., Agrimi, U., Nonno, R., & Chiocchetti, R. (2013) · Research in Veterinary Science · doi:10.1016/j.rvsc.2013.07.028 · Cited by 12
“, 2010), may be of crucial relevance for a precise characterization of the subsequent steps of the neuroinvasion process, the long journey of prions from host’s peripheral tissues to CNS (Aguzzi and Heikenwalder, 2006; Mabbott and MacPherson, 2006).”
BackgroundCharacterization of sheep (Ovis aries) palatine tonsil innervation
Russo, D., Fantaguzzi, C. M., Guardo, G. D., Clavenzani, P., Costerbosa, G. L., Ligios, C., & Chiocchetti, R. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.04.015 · Cited by 9
Tsou, A., Chen, P.-J., Tsai, K., Hu, W., & Lu, K. (2022) · Viruses · doi:10.3390/v14020408 · Cited by 9
“These responses may be minimal or pro-inflammatory [38,39], involving several cytokines, including TNF-alpha, interleukin-1, and interleukin-6 [40–42].”
BackgroundAnalysis of miRNA Signatures in Neurodegenerative Prion Disease
Bellingham, S. A., & Hill, A. F. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7244-9_6 · Cited by 9
“Prion diseases are also transmissible with possible routes of infection through dietary exposure, medical procedures, and blood transfusion (reviewed in [2]).”
BackgroundChanging how we think about infectious diseases
Berman, J. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817576-7.00008-0 · Cited by 12
“Prions are not confined to mammals, and not confined to the brain [20] .”
Ali, T., Cashion, J., Hannaoui, S., Ahmed-Hassan, H., Schätzl, H. M., & Gilch, S. (2025) · JCI Insight · doi:10.1172/jci.insight.190296 · Cited by 9
“PrP Sc accumulation is a hallmark of prion diseases, and its presence is associated with neurodegeneration and the spread of prion pathology (1–8).”
The G127V variant of the prion protein interferes with dimer formation in vitro but not in cellulo
Sangeetham, S. B., Engelke, A. D., Fodor, E., Krausz, S. L., Tatzelt, J., & Welker, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-82647-w · Cited by 8
Tabrett, C. A., Harrison, C. F., Schmidt, B., Bellingham, S. A., Hardy, T., Sanejouand, Y., Hill, A. F., & Hogg, P. J. (2010) · Biochemical Journal · doi:10.1042/bj20091635 · Cited by 11
Translational Research in Alzheimer’s and Prion Diseases
Fede, G. D., Giaccone, G., Salmona, M., & Tagliavini, F. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170770 · Cited by 9
Kovač, V., & Šerbec, V. Č. (2018) · Biomarker Insights · doi:10.1177/1177271918756648 · Cited by 8
Dexter, E., & Kong, Q. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1965882 · Cited by 8
Protein-Based Neuropathology and Molecular Classification of Human Neurodegenerative Diseases
Kovács, G. G., & Budka, H. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_11 · Cited by 10
Gene expression profiling to identify druggable targets in prion diseases
Benetti, F., Gasperini, L., Zampieri, M., & Legname, G. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903544449 · Cited by 8
“Brain and spleen play a role in prion replication and present different glycomes [69,70].”
BackgroundMetallothionein-3, Zinc, and Copper in the Central Nervous System
Vašák, M., & Meloni, G. (2009) · Royal Society of Chemistry eBooks · doi:10.1039/9781847559531-00319 · Cited by 9
All quiet on the neuronal front: NMDA receptor inhibition by prion protein
Steele, A. D. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803152 · Cited by 8
“Highly expressed in neurons, PrP is also present in many other cell types ( Aguzzi and Heikenwalder, 2006 ).”
BackgroundVacuolar degeneration affecting brain macrophages/microglia in variant CJD: a report on two cases
Rezaie, P., & Al‐Sarraj, S. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0294-6 · Cited by 7
“In peripheral tissues, abnormal prion protein is replicated almost exclusively within the lympho-reticular system and follicular dendritic cells [2].”
BackgroundIVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease
Gu, H., Kirchhein, Y., Zhu, T. Z., Zhao, G., Peng, H., Du, E., Liu, J., Mastrianni, J. A., Farlow, M. R., Dodel, R. C., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1228-0 · Cited by 7
Demonceau, C., Marshall, A., Sales, J., & Heinen, E. (2009) · European Journal of Histochemistry · doi:10.4081/1192 · Cited by 7
“…and translocation to nerves (Kitamoto et al., 1991; McBride et al., 1992; O'Rourke et al., ORIGINAL PAPER 1994; Fraser et al., 1996; Klein et al., 1997; Klein et al., 1998; Brown et al., 1999; Mabbott et al., 2000; Raeber et al., 2001; Aguzzi & Heikenwalder, 2006; Mabbott & MacPherson, 2006).”
BackgroundIleal tract and Peyer’s patch innervation in scrapie-free versus scrapie-affected ovines
Marruchella, G., Ligios, C., Baffoni, M., Cancedda, M. G., Demontis, F., Donatucci, G., Chiocchetti, R., Clavenzani, P., Lalatta‐Costerbosa, G., & Guardo, G. D. (2009) · Archives of Virology · doi:10.1007/s00705-009-0361-5 · Cited by 7
“In lymphoid tissues, PrPd deposition occurs early within the germinal centres of B-cell follicles in both follicular dendritic cells (FDCs) and in macrophages [21], while enteric nervous system (ENS) plexi probably act as the initial site of neuroinvasion for prions, which may subsequently gain access to the CNS throu…”
BackgroundInfluentialAdvances in the development of antibody-based immunotherapy against prion disease
Gu, H., Dodel, R., Farlow, M., & Du, Y.-S. (2014) · Antibody Technology Journal · doi:10.2147/anti.s53336 · Cited by 7
“Accordingly, PrP represents a primary target for therapeutic strategies.(31) The expression of PrP is not restricted to the brain but occurs also in peripheral tissues including normal human lymphocytes, monocytes, neutrophils, and lymphoid cells.”
Molecular Characterization of the Rocky Mountain Elk (Cervus elaphus nelsoni) PRNP Putative Promoter
Seabury, C. M., Gill, C. A., Templeton, J. W., Dyar, J. B., Derr, J. N., Adelson, D. L., Owens, E. K., Davis, D. S., Kraemer, D. C., & Womack, J. E. (2007) · Journal of Heredity · doi:10.1093/jhered/esm091 · Cited by 9
“However, previous studies suggest that PrPC may play a role in immunoregulation, signal transduction, copper binding, synaptic homeostasis, apoptosis, and antiapoptosis (for review, see Aguzzi and Polymenidou 2004; Aguzzi and Heikenwalder 2006).”
BackgroundZhang, J. (2011) · arXiv (Cornell University) · doi:10.48550/arxiv.1106.4628 · Cited by 7
Classical bovine spongiform encephalopathy and chronic wasting disease: two sides of the prion coin
Haley, N. J., & Richt, J. A. (2023) · Animal Diseases · doi:10.1186/s44149-023-00087-7 · Cited by 6
“As with other TSEs, there is no specific immunologic response to the PrP Sc agent (Aguzzi and Heikenwalder 2006).”
BackgroundAspectos actuales de las infecciones emergentes y reemergentes
Angulo, G. B., & Sánchez, E. A. H. (2015) · Cited by 6
Thüne, K., Schmitz, M., Villar‐Piqué, A., Altmeppen, H. C., Schlomm, M., Zafar, S., Glatzel, M., Llorens, F., & Zerr, I. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1667231 · Cited by 6
“form PrP Scrapie (PrP) in a self-propagating manner [3,4].”
BackgroundChronic wasting disease prions in mule deer interdigital glands
Ness, A., Zeng, D., Kuznetsova, A., Otero, A., Kim, C., Saboraki, K., Lingle, S., Pybus, M. J., Aiken, J. M., Gilch, S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275375 · Cited by 6
“Circulating immune cells carrying PrP CWD or PrP Sc in prion infected animals are known to be concentrated in sites of inflammation—making them easier to identify by immunohistochemistry [48–54].”
Impaired spleen structure and chemokine expression in ME7 scrapie-infected mice
Kim, S., Han, S., Lee, H. S., Kim, Y., Choi, E., & Kim, M. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.03.008 · Cited by 6
“…have demonstrated that prions are transported to the blood and colonise the secondary lymphoid tissues before migration into the CNS (Aguzzi and Heikenwalder, 2006; Fraser cture and chemokine expression in ME7 scrapie-infected mice. and Dickinson, 1970, 1978; Mabbott and MacPherson, 2006;…”
BackgroundAutophagy in cancer and protein conformational disorders
Attanasio, S. (2025) · FEBS Letters · doi:10.1002/1873-3468.70061 · Cited by 5
“Notably, transmissible spongiform encephalopathies (TSEs) are a group of rare neurodegenerative diseases characterized by the aggregation of misfolded prion proteins (PrP) [128].”
Specific and Surrogate Cerebrospinal Fluid Markers in Creutzfeldt–Jakob Disease
Zanusso, G., Fiorini, M., Righetti, P. G., & Monaco, S. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7197-5_17 · Cited by 5
Sangeetham, S. B., Huszár, K., Bencsura, P., Nyeste, A., Hunyadi‐Gulyás, É., Fodor, E., & Welker, E. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.027 · Cited by 6
Prion protein inCaenorhabditis elegans: Distinct models of anti-BAX and neuropathology
Park, K.-W., & Li, L. (2011) · Prion · doi:10.4161/pri.5.1.14026 · Cited by 5
“The coding sequence for mouse PrP(1-254) carrying the 3F4 epitope was PCR amplified from the PrP1-254-mPrP1,(28) using the following primers: 5'-GCG CGG CTA GCA TGG CGA ACC TTG GCT ACT GG-3' (forward), 5'-GCG CGG AGC TCT CAT CCC ACG ATC AGG AAG ATG A-3' (reverse).”
BackgroundMethodInfluentialCorrection: CD36 Participates in PrP106–126-Induced Activation of Microglia
Kouadir, M., Yang, L., Tan, R., Shi, F., Lu, Y., Zhang, S., Yin, X., Zhou, X., & Zhao, D. (2012) · PLoS ONE · doi:10.1371/annotation/f900d37b-3d36-4551-8680-cecf4bd1418d · Cited by 5
Effect of Microglial Inflammation in Prion Disease
Ano, Y., Sakudo, A., & Onodera, T. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.036.001 · Cited by 4
Kang, S., Roh, Y. M., Kang, M. L., Kim, Y., & Yoo, H. S. (2010) · Prion · doi:10.4161/pri.4.1.11218 · Cited by 4
“Transmissible spongiform encephalopathies (TSEs), or prion diseases, are inevitably fatal, and there is no effective therapy.(1) Although prion diseases have been recognized for decades, or even centuries, important questions still remain regarding the nature of the infectious agents, the mechanisms of prion replicati…”
BackgroundQiao, J., Su, X., Li, Y.-X., Yang, J.-M., Wang, Y., Kouadir, M., Zhou, X., Yang, L., Yin, X., & Zhao, D. (2009) · Animal Biotechnology · doi:10.1080/10495390902996863 · Cited by 4
Treatment by CpG or Flt3-ligand does not affect mouse susceptibility to BSE prions
Doré, G. R. G., Leclerc, C., & Lazarini, F. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.03.016 · Cited by 4
“Prion replication does not seem to be immunotoxic nor to be pathogenic in other tissues than central nervous system (Aguzzi and Heikenwalder, 2006).”
BackgroundPrP 106-126 Altered PrP mRNA gene expression in mouse microglia BV-2 Cells
Bai, Y., Li, Y., Wang, G., Zhou, X., & Zhao, D. (2010) · Virologica Sinica · doi:10.1007/s12250-010-3143-z · Cited by 4
Prolonged follicular helper T cell responses in ME7 scrapie-infected mice
Kim, S., Han, S., Kim, T. H., Nam, J., Kim, Y., Choi, E., & Kim, M. (2018) · Prion · doi:10.1080/19336896.2018.1458573 · Cited by 4
EKSOZOMLAR VE NÖRODEJENERATİF HASTALIKLARLA İLİŞKİSİ
Kanan, D. D., GÜNEY, Ö., & Aksu, F. (2022) · Sağlık Bilimleri Dergisi · doi:10.34108/eujhs.861542 · Cited by 3
Nash, A. A., Dalziel, R. G., & Fitzgerald, J. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397188-3.00010-x · Cited by 3
Soil as an Environmental Reservoir of Prion Diseases
Nieder, R., Benbi, D. K., & Reichl, F. (2018) · Springer eBooks · doi:10.1007/978-94-024-1222-2_14 · Cited by 3
George‐Hyslop, P. S. (2008) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000275624.01820.a9 · Cited by 3
“The exact explanation is not yet proven but may relate to more efficient recruitment of homo-monomers into prion protein (PrP) aggregates and fibrils (Aguzzi and Heikenwalder, 2006).”
BackgroundDoxycyclin bei der sporadischen Creutzfeldt-Jakob-Krankheit
Fincke, F. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-972 · Cited by 3
Goldansaz, S. A., Hailemariam, D., Dervishi, E., Zwierzchowski, G., Wójcik, R., Wishart, D. S., & Ametaj, B. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136245 · Cited by 2
“Detection of disease-associated prion protein (PrP Sc ) was performed following the protocol described by Bell et al. [40], optimized to achieve maximal clearance of native cellular prion protein (PrP C ).”
Altered lymphocyte homeostasis after oral prion infection in mouse
Segundo, F. D.-S., Sevilla, N., Gutiérrez, J. P., & Brun, A. (2008) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2007.11.013 · Cited by 2
“prion inoculation ( Aguzzi and Heikenwalder, 2006 ).”
Prion protein and the red cell
Anstee, D. J. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3280d2b757 · Cited by 2
Furr, A., Knudsen, D. E. B., Hildreth, M. B., & Young, A. J. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.06.008 · Cited by 2
“…immune cells including 1 Abbreviations: Transmissible spongiform encephalopathies, TSE; Follicular dendritic cells, FDC; Central nervous system, CNS; Chronic wasting disease, CWD; Germinal center, GC. macrophages and dendritic cells (Mabbott and Bruce, 2002; Aguzzi and Heikenwalder, 2005, 2006).”
BackgroundIntroduction to Prion Disorders
Aguzzi, A., & Kana, V. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch31 · Cited by 1
Self-citationDemonceau, C., Piret, J., Zorzi, D., Thellin, O., & Heinen, E. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.04.004 · Cited by 1
Ahmad, K., Baig, M. H., Srivastava, A., & Khan, S. A. (2013) · Cited by 1
Immunobiology of Prion Diseases
Xanthopoulos, K., Dafou, D., Kanata, Ε., & Sklaviadis, T. (2017) · InTech eBooks · doi:10.5772/66447 · Cited by 1
“While these models provide a wealth of information regarding pathogenesis, it later became evident that different mechanisms are involved in the pathogenesis of prion infection following the intraperitoneal or the oral route of infection [26], and other factors such as the pathogen strain and the host species and/or s…”
Protective Role of Cellular Prion Protein in Tissues Ischemic/Reperfusion Injury
Wang, Z., & Zou, W. (2023) · Springer eBooks · doi:10.1007/978-3-031-20565-1_24 · Cited by 1
Quinn, E., Merritt, T. D., Buckland, M. E., & Tobin, S. (2014) · Public Health Research & Practice · doi:10.17061/phrp2511409 · Cited by 1
Nanoporous membrane-encapsulated feeder cells for culture of human embryonic stem cells
Zhou, J., Xu, R. H., & Wang, Y. (2009) · International Journal of Functional Informatics and Personalised Medicine · doi:10.1504/ijfipm.2009.022838 · Cited by 1
Blood-transmitted prions and variant Creutzfeldt–Jakob disease
Grady, G. F., & Vyas, G. N. (2007) · Biologicals · doi:10.1016/j.biologicals.2007.01.005 · Cited by 1
Moncada, M. (2019) · theses.fr (ABES) · doi:10.70675/37f1b907z83eaz4068z94a6z9f4747200dc3 · Cited by 2
Roles of manganese and protein kinase signaling in cell culture and animal models of prion disease
Martin, D. P. (2013) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-721
“The major neurological symptoms of TSE are extrapyramidal motor signs, including tremors, postural instability, ataxia, and myoclonus (Aguzzi and Heikenwalder, 2006; Brandner, 2003; Brown, 2002; Tatzelt and Schatzl, 2007).”
BackgroundUsing Drosophila to Reveal Insight into Protein Misfolding Diseases
Bilen, J., & Bonini, N. M. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch10
Carpinelli, G., Canese, R., Vetrugno, V., Bari, M. A. D., Santoro, F., Lu, M., Sbriccoli, M., Pocchiari, M., Agrimi, U., & Podo, F. (2009) · Magnetic Resonance Insights · doi:10.4137/mri.s2550
Hybrid Method of Discrete Gradient with Simulated Annealing or Genetic Algorithm
Zhang, J. (2015) · Focus on structural biology · doi:10.1007/978-94-017-7318-8_12
Compared with the NMR Structure and Dynamics of Dogs and Horses
Zhang, J. (2015) · Focus on structural biology · doi:10.1007/978-94-017-7318-8_5
The Inflammatory Component of Neurodegenerative Diseases
Ferrari, C. C., & Pitossi, F. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-30398-7_18
Blair, J. L., Clinkenbeard, K. D., Ritchey, J. W., d’Offay, J. M., DeSilva, U., Emslie, A. G., Murray, L., & Cremeens, P. (2007)
Oikonomou, P. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6174
Towards a Comparison of the Folding of Prion Protein from Different Species
Charrunchon, S. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3vq2sq6f
Investigating the functional roles of microRNA-29b and microRNA-146a in prion diseases
Zhao, W. (2018) · Minerva Access (University of Melbourne)
Cellular prion level in the animals’ tissues
Kushkevych, M. V., Kozak, М. R., Petruh, I. M., & Влизло, В. В. (2018) · Bulletin Veterinary biotechnology · doi:10.31073/vet_biotech32(2)-75
Structural Characterization of Amyloid Assemblies and Amyloid Protein-lipid Interactions
Yau, J. (2016) · TSpace (University of Toronto)
Pathophysiology of Neurodegenerative Diseases: Basics to Advanced
Manoharan, S. K., & Kumar, P. S. (2020) · Springer eBooks · doi:10.1007/978-981-15-5167-3_5
A Prion Protein Gene Polymorphism at Codon 138 Modulates Chronic Wasting Disease Pathogenesis
Arifin, M. I. (2021) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/39109 · Cited by 1
Shastri, A., Marco, D., & Kishore, U. (2013) · InTech eBooks · doi:10.5772/53460
“Prion proteins are found normally in the cells of central nervous system and immune system [106].”
BackgroundEffect of Microglial Inflammation in Prion Disease
Ano, Y., Sakudo, A., & Onodera, T. (2018) · Caister Academic Press eBooks · doi:10.21775/9781910190951.03
Dimerization of the prion protein studied by site specific mutagenesis to p-benzoyl-L-phenylalanine
Sangeetham, S. B. (2022) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.11102
Metadata
- Authors
- Aguzzi, A., & Heikenwalder, M.
- Affiliations
- University Hospital Zurich (CH)
- Corresponding author
- Aguzzi, Adriano
- ORCID
- Aguzzi, Adriano
- Venue
- Nature Reviews Microbiology
- Published
- 2006-10
- Volume
- 4
- Issue
- 10
- Pages
- 765-775
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2081750840
- Cited by
- 207
- References
- 163
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 7 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 11 · 2017: 9 · 2016: 7 · 2015: 5 · 2014: 9 · 2013: 11 · 2012: 11
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- prion disease, prion pathogenesis, immune system, prion replication, neurodegeneration, secondary lymphoid organs, chronic inflammation, prion protein conformation
- MeSH terms
- Animals, Humans, Ruminants, Prion Diseases, PrPSc Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.